| Clinical data | |
|---|---|
| Other names | 2-Ethyl-4-(2-fluorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C17H15FN4S |
| Molar mass | 326.39 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Fluetizolam (2-ethyl-4-(2-fluorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine) is athienotriazolodiazepine derivative with potentsedative andanxiolytic effects, which has been sold as adesigner drug.[1][2]